{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:18:15Z","timestamp":1697527095702},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T00:00:00Z","timestamp":1264118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p>Secondary resistance of gastrointestinal stromal tumors (GISTs) to tyrosine kinase inhibitors occurs after several years\u2019 administration. However, the mechanism of resistance has not been fully clarified. In this study, we analyzed the genotypes and the histologic and immunohistochemical phenotypes of metastatic GISTs with and without imatinib treatment, and clarified the pleomorphic nature of metastatic GISTs. We examined 31 autopsy cases in which the patients died of multiple metastases of GISTs, and two surgically resected specimens with and without imatinib treatment. A total of 152 primary and metastatic lesions in 33 cases of GISTs were examined for histologic and immunohistochemical expression of KIT and CD34. We analyzed the expression of other receptor tyrosine kinases (RTKs) in KIT\u2010negative lesions, including human EGFR\u2010related 2 (HER2), epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (MET), platelet\u2010derived growth factor receptor\u2010\u03b1 (PDGFRA), and platelet\u2010derived growth factor receptor\u2010\u03b2 (PDGFRB). Fifteen lesions in seven cases (9.9%) lacked KIT expression, and 74 (49%) in 22 cases lacked CD34 expression. Eight KIT\u2010negative lesions in five cases expressed PDGFRB, one of which also expressed EGFR, and three lesions in one case expressed MET. Results for the other RTKs were negative. Missense point mutations at <jats:italic>PDGFRB<\/jats:italic> gene exon 12 were detected in one PDGFRB\u2010positive case. Our results indicate that histomorphology, immunohistochemical phenotypes, and genotypes of metastatic GISTs vary among lesions, even in cases without imatinib treatment. A KIT\u2010independent mechanism, such as activation of other RTKs, might participate in the proliferation of late\u2010stage GISTs and might be a cause of secondary imatinib resistance.<\/jats:p><jats:p>(<jats:italic>Cancer Sci<\/jats:italic> 2010; 101: 1270\u20131278)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2010.01510.x","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T13:37:17Z","timestamp":1264167437000},"page":"1270-1278","source":"Crossref","is-referenced-by-count":3,"title":["Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment"],"prefix":"10.1111","volume":"101","author":[{"given":"Kazuha","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Hironaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Keira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Niki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004280000338"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.123545"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577"},{"key":"e_1_2_6_5_2","first-page":"728","article-title":"CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34","volume":"11","author":"Sarlomo\u2010Rikala M","year":"1998","journal-title":"Mod Pathol"},{"key":"e_1_2_6_6_2","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin BP","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64946-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079666"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.02977.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17098-0"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.020"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.2265"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-008-0102-z"},{"key":"e_1_2_6_15_2","first-page":"26","article-title":"Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib\u2010resistant gastrointestinal stromal tumor","volume":"20","author":"Heinrich MC","year":"2008","journal-title":"Clin Oncol"},{"key":"e_1_2_6_16_2","first-page":"12","article-title":"Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate","volume":"15","author":"Wardelmann E","year":"2006","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00727.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02179.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2382"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31817ec2e6"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-003-0321-0"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02081.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji112"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20629"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036335"},{"key":"e_1_2_6_26_2","first-page":"3719","article-title":"The dermatofibrosarcoma protuberans\u2010associated collagen type Ialpha1\/platelet\u2010derived growth factor (PDGF) B\u2010chain fusion gene generates a transforming protein that is processed to functional PDGF\u2010BB","volume":"59","author":"Shimizu A","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710370104"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1141478"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn240"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203455"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2881"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02128.x"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2010.01510.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2010.01510.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:58:11Z","timestamp":1697428691000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2010.01510.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,19]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1349-7006.2010.01510.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01510.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,19]]}}}